Filing Details
- Accession Number:
- 0001387131-16-005689
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-26 12:08:07
- Reporting Period:
- 2016-05-25
- Filing Date:
- 2016-05-26
- Accepted Time:
- 2016-05-26 12:08:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1173281 | Ohr Pharmaceutical Inc | OHRP | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1630109 | Scott Jason Slakter | C/O Ohr Pharmaceutical Inc. 800 Third Ave, 11Th Floor New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 500 | $3.09 | 913,072 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 100 | $3.11 | 913,172 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 300 | $3.14 | 913,472 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 100 | $3.14 | 913,572 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 682 | $3.13 | 914,254 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2016-05-25 | 2,000 | $3.10 | 916,254 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | 697,865 | Indirect | By SKS Ocular I LLC |
Footnotes
- SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
